Avalo Therapeutics (traded under the ticker symbol AVTX) is listed on public stock exchanges, providing liquidity for institutional and retail shareholders. As a micro-cap clinical-stage biopharmaceutical enterprise, its ordinary shares trade on major electronic quotation platforms and public exchanges, allowing investors to buy and sell securities during normal daily market operational hours while adhering to standard regulatory compliance and reporting standards.